117 related articles for article (PubMed ID: 1530680)
1. Gastric potential difference measurement as a quantification of gastrointestinal tolerability comparing a buffered acetylsalicylic acid formulation versus plain acetylsalicylic acid.
Jost V; Kuhn I; Rogalla K; Theiss U; Lücker PW
Arzneimittelforschung; 1992 May; 42(5):650-3. PubMed ID: 1530680
[TBL] [Abstract][Full Text] [Related]
2. Comparative gastric irritation by two buffered acetylsalicylic acid formulations and acetylsalicylic acid. A gastric potential difference analysis.
Bruhn R; Ganote DP; Lücker PW; Vance J; Procaccini RL
Arzneimittelforschung; 1983; 33(1):158-60. PubMed ID: 6681968
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic study of a new oral buffered acetylsalicylic acid (ASA) formulation in comparison with plain ASA in healthy volunteers.
Viganò G; Garagiola U; Gaspari F
Int J Clin Pharmacol Res; 1991; 11(3):129-35. PubMed ID: 1809699
[TBL] [Abstract][Full Text] [Related]
4. Gastric tolerance of single dose unbuffered and buffered acetylsalicylic acid: a randomized comparative endoscopic study in 24 volunteers.
Rogalla K; Lange R; Panijel M
Int J Clin Pharmacol Res; 1992; 12(3):133-8. PubMed ID: 1473880
[TBL] [Abstract][Full Text] [Related]
5. In vivo-in vitro correlations with various aspirin formulations.
Alcorn GJ; Lücker PW; Procaccini RL; Ritschel WA
Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):761-7. PubMed ID: 3448453
[TBL] [Abstract][Full Text] [Related]
6. Preventing acetylsalicylic acid damage to human gastric mucosa by use of prostaglandin E2.
Cohen MM; Clark L
Can J Surg; 1983 Mar; 26(2):116-8. PubMed ID: 6824996
[TBL] [Abstract][Full Text] [Related]
7. [Measuring the potential difference of gastric mucosa as a means of quantifying the protective effect of Al-acetylglycyrrhetinate after a dose of acetylsalicylic acid (author's transl)].
Altmayer P; Lücker PW; Kolb KH
Arzneimittelforschung; 1981; 31(5):853-6. PubMed ID: 7196748
[TBL] [Abstract][Full Text] [Related]
8. Effects of ibuprofen lysinate and acetylsalicylic acid on gastric and duodenal mucosa. Randomized single-blind placebo-controlled endoscopic study in healthy volunteers.
Müller P; Simon B
Arzneimittelforschung; 1994 Jul; 44(7):840-3. PubMed ID: 7945519
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and relative bioavailability of a new chewable, buffered acetylsalicylic acid tablet formulation in comparison to a conventional plain tablet.
Lücker PW; Wetzelsberger N; Schettler T; Rogalla K
Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):805-11. PubMed ID: 1297896
[TBL] [Abstract][Full Text] [Related]
10. [Transmural gastric potential difference (PD) and intragastric diurnal pH profile with proglumide].
Lembcke B; Lembcke C; Caspary WF
Z Gastroenterol; 1983 Jul; 21(7):342-50. PubMed ID: 6613215
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic comparison of three aspirin preparations and placebo.
Petroski D
Clin Ther; 1993; 15(2):314-20. PubMed ID: 8519040
[TBL] [Abstract][Full Text] [Related]
12. [The effect of acetylsalicylic acid on gastric transmural potential difference in healthy children and in children with inflammatory diseases].
König A; Jährig K; Nikolaides N
Z Gastroenterol; 1989 Jun; 27(6):317-20. PubMed ID: 2773529
[TBL] [Abstract][Full Text] [Related]
13. The effects of acetylsalicylic acid on the human gastric mucosa as revealed by gastrocamera.
Edmar D
Scand J Gastroenterol; 1975; 10(5):495-9. PubMed ID: 1098134
[TBL] [Abstract][Full Text] [Related]
14. Acetylsalicylic acid and gastrointestinal bleeding measurement of blood loss using a modified radioactive chromium method.
Arvidsson B; Magnusson B; Sölvell ; Magnusson A
Scand J Gastroenterol; 1975; 10(2):155-60. PubMed ID: 1091965
[TBL] [Abstract][Full Text] [Related]
15. Gastric irritation of oxaprozin, a new nonsteroidal, antiinflammatory drug, in comparison to acetylsalicylic acid and indomethacin: a gastric potential difference analysis.
Lücker PW; Venitz J; Ahrens S; Kaiser PM
Methods Find Exp Clin Pharmacol; 1987 Jul; 9(7):469-75. PubMed ID: 3683021
[TBL] [Abstract][Full Text] [Related]
16. [Acetlysalicylic acid, protective antacid effect and lesions of the gastric mucosa. Effect of acetylsalicylic acid and an antacid drug (Gastropulgit Tabs) on the transmural electric potential in the human stomach].
Caspary WF; Kausch H
Fortschr Med; 1979 Aug; 97(30-31):1333-6. PubMed ID: 468096
[TBL] [Abstract][Full Text] [Related]
17. Ascorbic acid attenuates aspirin-induced gastric damage: role of inducible nitric oxide synthase.
Konturek PC; Kania J; Hahn EG; Konturek JW
J Physiol Pharmacol; 2006 Nov; 57 Suppl 5():125-36. PubMed ID: 17218764
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
[TBL] [Abstract][Full Text] [Related]
19. The absorption of acetylsalicylic acid from the stomach in relation to intragastric pH.
Dotevall G; Ekenved G
Scand J Gastroenterol; 1976; 11(8):801-5. PubMed ID: 12558
[TBL] [Abstract][Full Text] [Related]
20. [Circadian aspects of acetylsalicylic acid induced injury and protective effect of ranitidine on the the upper gastrointestinal tract].
Müller P; Arce L; Jackisch P; Simon B
Arzneimittelforschung; 1994 Aug; 44(8):962-5. PubMed ID: 7945542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
